This site uses cookies to improve user experience by collecting data. By continuing to use this website, you agree to the use of cookies and similar technologies as described in our Privacy Policy.
Accept
Decline
MENU
CLOSE
language
Powerful, accessible cell therapies for patients with cancer.

We develop innovative, highly effective cell therapies for cancer that are broadly accessible for patients.
FIND US
Acepodia USA
1600 Harbor Bay Parkway, Suite 140,
Alameda, CA 94502,
USA
Acepodia Taiwan
12F., No. 508, Sec. 7, Zhongxiao E. Rd.,
Nangang Dist., Taipei City 115011,
Taiwan (R.O.C.).
CONTACT US
Tel: +1 (415) 366 7822 Email: info@acepodiabio.com
FOLLOW US
Copyright © 2020 Acepodia Inc.
Privacy Policy Terms of use

Investors

CONTACT

If you have any questions or suggestions about investor services, please email   ir@acepodiabio.com
We sincerely thank you for your support to Acepodia.

Stock Transfer Agent
Taishin Securities Co., Ltd., Stock Transfer Agency Department

Tel: (02) 2504-8125 ext. 9

Address: B1, No. 96, Sec. 1, Jianguo N. Rd., Zhongshan Dist., Taipei City

Mailing Address:
P.O. Box 46-300, Taipei, Taiwan 104946

Website: 
https://www.tssco.com.tw/stocktransfer

 

Remuneration Committee

1. Remuneration Committee
The Company established its Remuneration Committee on April 26, 2023, composed of all independent directors.
The Committee's responsibilities are as follows:
(a)Periodically review these regulations and propose amendments.
(b)Formulate and periodically review performance evaluation standards, annual and long-term performance targets,
     and remuneration policies, systems, standards, and structures for directors and executives.
(c)Periodically evaluate the achievement of performance targets by directors and executives, and determine
     individual remuneration content and amounts based on performance evaluation results.
 
2. 2nd Remuneration Committee — Term: February 6, 2026 to February 5, 2029
 
Title Name
Independent Director Jo Shen (Convener)
Independent Director Angus Tsai
Independent Director Kunming Rao
Independent Director Sung-Hsin Kuo

3. Remuneration Committee Attendance
 
As of June 2026, the Committee has held 2 meetings (A). Attendance is as follows:
Member Actual Attendance (B) Attended by Proxy Attendance Rate (B/A)
Jo Shen 2 0 100%
Angus Tsai 2 0 100%
Kunming Rao 2 0 100%
Sung-Hsin Kuo 2 0 100%